Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported financial results for the three months ended September 30, 2017, and provided other general business updates. “We are …
Intercept Pharma (NASDAQ: ICPT) released its fourth quarter and full year 2014’s financial results on March 2nd. The biopharmaceutical company focuses on chronic liver …
In a research report published Friday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Intercept Pharmaceuticals (NASDAQ:ICPT) with a price target of …
In a research report released Friday, Deutsche Bank analyst Alethia Young maintained a Buy rating on Intercept Pharma (NASDAQ:ICPT) with a price target …
Cowen’s healthcare analyst Ritu Baral is weighing in with her thoughts on Intercept Pharmaceuticals (NASDAQ:ICPT), following the news that the company’s investigational product obeticholic acid (OCA) …
In a research report sent to investors, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Intercept Pharmaceuticals (NASDAQ:ICPT) with a price target …
Cowen analyst Ritu Baral maintained an Outperform rating on Intercept Pharmaceuticals (NASDAQ:ICPT) with a price target of $420, as the company provided a clinical update …
